Tubbs R R, Sheibani K, Hawk W A
Arch Pathol Lab Med. 1980 May;104(5):245-6.
Giant cell myocarditis (GCM) as a distinct disease entity has been questioned. The superficial morphologic resemblance to cardiac sarcoidosis and incomplete histopathologic assessment of extracardiac organ systems in reported cases has suggested that GCM represents a predominant cardiac manifestation of generalized sarcoidosis. The morphologic and immunocytochemical features at autopsy of this rare disorder were seen in a 15-year-old boy. All other organs were free of granulomatous inflammation. Transition from normal myocardial fibers to giant cells was observed, without a limiting plasma membrane between the two different aspects of the fiber. Immunocytochemistry for cytoplasmic muramidase (CM) showed CM in neutrophils and tissue macrophages. Cytoplasmic muramidase was distinctly absent from the characteristic giant cells. The classification of GCM as a disease separate from generalized sarcoidosis may be justified.
巨细胞性心肌炎(GCM)作为一种独特的疾病实体一直受到质疑。据报道,其在表面形态上与心脏结节病相似,且对心外器官系统的组织病理学评估不完整,这表明GCM是全身性结节病的主要心脏表现。在一名15岁男孩的尸检中发现了这种罕见疾病的形态学和免疫细胞化学特征。所有其他器官均无肉芽肿性炎症。观察到从正常心肌纤维向巨细胞的转变,在纤维的两个不同层面之间没有界限分明的质膜。细胞质溶菌酶(CM)的免疫细胞化学显示中性粒细胞和组织巨噬细胞中有CM。特征性巨细胞中明显没有细胞质溶菌酶。将GCM归类为与全身性结节病不同的疾病可能是合理的。